Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.53 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 1/20 | 0.53 |
| ▸ | RXRG | P48443 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | NAMPT | P43490 | 1/20 | 0.49 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.45 |
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9551460 | 0.88 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL8142983 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL16195513 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL6763906 | 0.81 | CYP1A2 (0.53) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL11006202 | 0.80 | ALDH1A1 (0.73) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL2095584 | 0.79 | RXRA (0.53) | RXRARXRBRXRGL3MBTL1 | |
| SCHEMBL19441062 | 0.79 | CYP1A2 (0.51) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL13050673 | 0.79 | CYP1A2 (0.51) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL5735923 | 0.79 | CYP1A2 (0.51) | ALDH1A1KDM4EGAARXRARXRB | |
| SCHEMBL16094351 | 0.79 | CYP1A2 (0.51) | ALDH1A1KDM4EGAARXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220218878-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2022-07-14 | — | — | US | claimed |
| WO-2020243047-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2020-12-03 | — | — | WO | claimed |
| CN-119053612-A | Method for purifying siloxane containing hydroxyl group and (meth) acryloyl group and siloxane composition containing hydroxyl group and (meth) acryloyl group | 信越化学工业株式会社 | 2024-11-29 | — | — | CN | disclosed |
| US-20240000782-A1 | METHODS AND COMPOSITIONS FOR TREATING AN OPHTHALMIC CONDITION | TELIOS PHARMA, INC. (US) | 2024-01-04 | — | — | US | disclosed |
| EP-4255569-A1 | METHODS AND COMPOSITIONS FOR TREATING AN OPHTHALMIC CONDITION | Telios Pharma, Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| CN-116829150-A | Methods and compositions for treating ocular conditions | 泰利奥斯制药公司 | 2023-09-29 | — | — | CN | disclosed |
| US-20220362381-A1 | REMOTELY TRIGGERED THERAPY | BAMBU VAULT LLC (US) | 2022-11-17 | — | — | US | disclosed |
| US-20220287949-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | BAMBU VAULT LLC (US) | 2022-09-15 | — | — | US | disclosed |
| US-20220226253-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | BAMBU VAULT LLC (US) | 2022-07-21 | — | — | US | disclosed |
| US-20220229065-A1 | SENSORS AND METHODS FOR RAPID MICROBIAL DETECTION | BAMBU VAULT LLC (US) | 2022-07-21 | — | — | US | disclosed |
| US-20220218878-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2022-07-14 | — | — | US | disclosed |
| US-20200390889-A1 | REMOTELY TRIGGERED THERAPY | BAMBU VAULT LLC (US) | 2020-12-17 | — | — | US | disclosed |
| WO-2020243047-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020123656-A1 | METHODS AND COMPOSITIONS OF TREATING AN OPHTHALMIC CONDITION | KARTOS THERAPEUTICS (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2017046598-A1 | TREATMENT OF ACUTE INFLAMMATORY DISORDERS | IMPERIAL INNOVATIONS LIMITED (GB) | 2017-03-23 | — | — | WO | disclosed |
| EP-3085757-A1 | STABILIZATION OF ALKOXYLATED POLYTETRAHYDROFURANES WITH ANTIOXIDANTS | BASF SE (DE) | 2016-10-26 | — | — | EP | disclosed |
| EP-0189049-B2 | Stabilization of palm kernel oil fatty-acid methyl esters for their processing into subsequent reaction products with a neutral colour | HENKEL KGAA (DE) | 1993-12-15 | — | — | EP | disclosed |
| EP-0473823-A1 | Laminate and process for producing the same | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1992-03-11 | — | — | EP | disclosed |
| EP-0189049-B1 | STABILIZATION OF PALM KERNEL OIL FATTY-ACID METHYL ESTERS FOR THEIR PROCESSING INTO SUBSEQUENT REACTION PRODUCTS WITH A NEUTRAL COLOUR | Henkel Kommanditgesellschaft auf Aktien (DE) | 1990-08-01 | — | — | EP | disclosed |
| EP-0189049-A1 | Stabilization of palm kernel oil fatty-acid methyl esters for their processing into subsequent reaction products with a neutral colour | Henkel Kommanditgesellschaft auf Aktien (DE) | 1986-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390889-A1 | REMOTELY TRIGGERED THERAPY | CD47, IFNG, TLR9 | ALDH1A1 3552/4885KDM4E 4290/4885GAA 1436/4885 |
| US-20220362381-A1 | REMOTELY TRIGGERED THERAPY | CD47, HSP90AA1, HSF1 | ALDH1A1 1357/4885KDM4E 2640/4885GAA 1118/4885 |
| US-20240000782-A1 | METHODS AND COMPOSITIONS FOR TREATING AN OPHTHALMIC CONDITION | BTK, SYK, LCK | ALDH1A1 3952/4885KDM4E 1813/4885GAA 1358/4885 |
| US-20220226253-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | CTSA, CES2, ACHE | ALDH1A1 632/4885KDM4E 4793/4885GAA 101/4885 |
| US-20220287949-A1 | SAFE PARTICLES FOR THE INTRODUCTION OF USEFUL CHEMICAL AGENTS IN THE BODY WITH CONTROLLED ACTIVATION | MPO, CUTA, LPO | ALDH1A1 220/4885KDM4E 4626/4885GAA 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.